164 related articles for article (PubMed ID: 27132181)
1. Proposal and Validation of a Basic Progression Scoring System for Patients with Skull Base Chordoma.
Ma JP; Tian KB; Wang L; Wang K; Li D; Yang Y; Du J; Ru XJ; Zhang LW; Wu Z; Zhang JT
World Neurosurg; 2016 Jul; 91():409-18. PubMed ID: 27132181
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
[TBL] [Abstract][Full Text] [Related]
3. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
4. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
5. Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution.
Pamir MN; Kiliç T; Türe U; Ozek MM
Acta Neurochir (Wien); 2004 Apr; 146(4):343-54; discusion 354. PubMed ID: 15057528
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the "Sekhar grading system for cranial Chordomas" in patients treated with pencil beam scanning proton therapy: an institutional analysis.
Hottinger AL; Bojaxhiu B; Ahlhelm F; Walser M; Bachtiary B; Zepter S; Lomax T; Pica A; Weber DC
Radiat Oncol; 2020 May; 15(1):96. PubMed ID: 32375820
[TBL] [Abstract][Full Text] [Related]
7. Factors for tumor progression in patients with skull base chordoma.
Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J
Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution.
Wu Z; Zhang J; Zhang L; Jia G; Tang J; Wang L; Wang Z
Neurosurg Rev; 2010 Oct; 33(4):451-6. PubMed ID: 20668904
[TBL] [Abstract][Full Text] [Related]
9. SNF5 as a prognostic factor in skull base chordoma.
Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y
J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701
[TBL] [Abstract][Full Text] [Related]
10. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
11. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
[TBL] [Abstract][Full Text] [Related]
14. Chondroid chordoma of the lateral skull base.
Rossiello R; Ferrara G; Varricchio A; Baldi A; Motta S; Motta G
ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):114-8. PubMed ID: 11244373
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups.
Tian K; Wang L; Wang K; Ma J; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
World Neurosurg; 2016 Aug; 92():407-417. PubMed ID: 27237421
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological study of chordoma in the skull base].
Nong H; Nong D; Nong X; Teng Y; Liang Y; Wu H; Wen W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):99-102. PubMed ID: 12768716
[TBL] [Abstract][Full Text] [Related]
17. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract][Full Text] [Related]
20. Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.
Tian K; Zhang H; Ma J; Wang K; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J; Wang L
World Neurosurg; 2017 Jan; 97():39-48. PubMed ID: 27671886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
